Global Gastric Cancer Therapy Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Therapy Type;
Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy and Surgery.Segmented by End User;
Ambulatory Surgery Centers, Hospitals and Specialty Clinics and Other End users.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Gastric Cancer Therapy Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 91.6 |
2021 | 96.5 |
2022 | 105.4 |
2023 | 123.2 |
2024 | 133.3 |
2025 | 158.4 |
2026 | 173.6 |
2027 | 196.8 |
2028 | 201.4 |
2029 | 214.2 |
2030 | 249.9 |
In the year 2023, the Global Gastric Cancer Therapy Market was valued at USD 8,525.63 million. The size of this market is expected to increase to USD 15,561.18 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.
Global Gastric Cancer Therapy Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Gastric Cancer Therapy Market |
Study Period | 2020 - 2030 |
Base Year (for Gastric Cancer Therapy Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Gastric Cancer Therapy Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Gastric Cancer Therapy Market Analysis
In this report, the Global Gastric Cancer Therapy Market has been segmented by Therapy Type, End User and Geography. Stomach cancer treatment success rate for 5 year is 32%. Stage 4 stomach cancer life expectancy with treatment is 20%. New treatment for stomach cancer includes drug called ramucirumab (cyramza). Stage 1 stomach cancer symptoms includes unexplained weight loss, abdominal pain or vague pain just above the belly button area, indigestion, heartburn or vomiting, loss of or decrease in appetite, weakness or fatigue, blood in vomit or stool, a feeling of fullness after small meals. One can detect it early by complete medical history and physical exam, upper gastrointestinal endoscopy to view the esophagus, stomach and small intestine after sedation, biopsy of stomach tissue to be evaluated under a microscope, ct scan to visualize organs during x-ray. Symptoms include blood in the stool, vomiting, weight loss for no known reason, stomach pain, jaundice (yellowing of eyes and skin), ascites (build-up of fluid in the abdomen), trouble swallowing.
Global Gastric Cancer Therapy Market, Segmentation by Therapy Type
The Global Gastric Cancer Therapy Market has been segmented by Therapy Type into Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy and Surgery. The complete Global Gastric Cancer Therapy Market segmentation by Therapy Type can be seen below:
- Global Gastric Cancer Therapy Market, By Therapy Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Radiation Therapy
- Surgery
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Therapy Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Therapy Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Gastric Cancer Therapy Market, by Therapy Type (USD Million), 2020 - 2030
# | Chemotherapy | Targeted Therapy | Immunotherapy | Radiation Therapy | Surgery |
---|---|---|---|---|---|
2020 | 68.2 | 53.8 | 63.6 | 89.6 | 101.9 |
2021 | 73.0 | 55.7 | 66.9 | 106.5 | 106.4 |
2022 | 84.4 | 61.4 | 77.6 | 114.5 | 118.3 |
2023 | 97.0 | 65.3 | 79.1 | 115.1 | 137.0 |
2024 | 104.8 | 65.6 | 81.4 | 121.8 | 148.9 |
2025 | 124.1 | 76.8 | 84.8 | 131.0 | 150.8 |
2026 | 127.9 | 89.6 | 90.6 | 154.4 | 163.9 |
2027 | 139.4 | 101.9 | 99.5 | 185.2 | 172.6 |
2028 | 145.7 | 113.8 | 117.2 | 208.5 | 204.9 |
2029 | 153.3 | 129.9 | 131.8 | 220.1 | 229.2 |
2030 | 154.5 | 145.8 | 155.9 | 221.1 | 238.9 |
Global Gastric Cancer Therapy Market, Segmentation by End User
The Global Gastric Cancer Therapy Market has been segmented by End User into Ambulatory Surgery Centers, Hospitals and Specialty Clinics and Other End users. The complete Global Gastric Cancer Therapy Market segmentation by End User can be seen below:
- Global Gastric Cancer Therapy Market, By End User
- Ambulatory Surgery Centers
- Hospitals and Specialty Clinics
- Other End users
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the End Users mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by End User is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Gastric Cancer Therapy Market, by End User (USD Million), 2020 - 2030
# | Ambulatory Surgery Centers | Hospitals and Specialty Clinics | Other End users |
---|---|---|---|
2020 | 53.9 | 71.4 | 97.5 |
2021 | 63.1 | 82.8 | 113.8 |
2022 | 66.4 | 98.2 | 134.1 |
2023 | 69.3 | 105.8 | 153.9 |
2024 | 75.4 | 110.9 | 181.7 |
2025 | 85.4 | 125.9 | 186.9 |
2026 | 87.0 | 132.0 | 208.4 |
2027 | 91.0 | 149.0 | 209.7 |
2028 | 107.8 | 173.8 | 241.1 |
2029 | 125.2 | 189.9 | 276.1 |
2030 | 138.6 | 225.7 | 292.6 |
Global Gastric Cancer Therapy Market, Segmentation by Geography
In this report, the Global Gastric Cancer Therapy Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Gastric Cancer Therapy Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Gastric Cancer Therapy Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Gastric Cancer Therapy in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Gastric Cancer Therapy Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Gastric Cancer Therapy Market is driven by; Growing Burden of Gastric Cancer and Introduction of Novel Therapies for Metastatic Stomach Cancer.
- While the growth of Global Gastric Cancer Therapy Market is currently hindered by; High Cost of Cancer Therapy and Side Effects of Cancer Drugs.
- The new opportunities in Global Gastric Cancer Therapy Market will be discussed in detail in the full report.
- Growing Burden of Gastric Cancer.
- Introduction of Novel Therapies for Metastatic Stomach Cancer.
- High Cost of Cancer Therapy and Side Effects of Cancer Drugs.
- Global Gastric Cancer Therapy Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Gastric Cancer Therapy Market. The opportunity map (by market segments; Therapy Type and End User) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Gastric Cancer Therapy Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Gastric Cancer Therapy Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Gastric Cancer Therapy Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Gastric Cancer Therapy Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Gastric Cancer Therapy Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Gastric Cancer Therapy Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Gastric Cancer Therapy Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Gastric Cancer Therapy Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Gastric Cancer Therapy Market include, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc. and Celltrion Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Market Opportunity Map
- Global Gastric Cancer Therapy Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Growing Burden of Gastric Cancer
- Introduction of Novel Therapies for Metastatic Stomach Cancer
- Restraints
- High Cost of Cancer Therapy and Side Effects of Cancer Drugs
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Gastric Cancer Therapy Market, By Therapy Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Chemotherapy
- Global Gastric Cancer Therapy Market, By End User, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Other End users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Ambulatory Surgery Centers
- Global Gastric Cancer Therapy Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Gastric Cancer Therapy Market, By Therapy Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Eli Lilly and Company
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pfizer Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck & Co. Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Celltrion Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Eli Lilly and Company
- Analyst Views
- Future Outlook of the Market